Strategies for colon cancer screening with considerations of cost and access to care

JNCCN Journal of the National Comprehensive Cancer Network

Volumn 8, Issue 1, 2010, Pages 2-5

  Burt, Randall W ^a,b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOMATOUS POLYP; BARIUM ENEMA; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER PREVENTION; CANCER RISK; CANCER SCREENING; COLON CANCER; COLONOSCOPY; COMPUTED TOMOGRAPHIC COLONOGRAPHY; COST EFFECTIVENESS ANALYSIS; EARLY DIAGNOSIS; ENTERITIS; FAMILY HISTORY; HEALTH CARE ACCESS; HEALTH CARE COST; HUMAN; MASS SCREENING; MEDICAL SOCIETY; NOTE; OCCULT BLOOD; PRACTICE GUIDELINE; RISK FACTOR; SIGMOIDOSCOPY;

EID: 76549100142     PISSN: 15401405     EISSN: 15401413     Source Type: Journal    
DOI: 10.6004/jnccn.2010.0002     Document Type: Note

References (18)

1. Levin B, McFarland B, Andrews KS, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the U.S. Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology 2008;134:1570-1595.
2. Ransohoff DF. Colon cancer screening in 2005: status and challenges. Gastroenterology 2005;128:1685-1695.
3. Lieberman DA. Screening for colorectal cancer. N Engl J Med 2009;361:1179-1187.
4. Frazier AL, Colditz GA, Fuchs CS, Kuntz KM. Cost-effectiveness of screening for colorectal cancer in the general population. JAMA 2000;284:1954-1961.
5. Office of Technology Assessment, U.S. Congress. Cost-effectiveness of colorectal cancer screening in average-risk adults. OTA-BP-H-146. Washington, DC: U.S. Government Printing Office: April 1995.
6. Ramsey SD, Mandelson MT, Berry K, et al. Cancer-attributable costs of diagnosis and care for persons with screen-detected versus symptom-detected colorectal cancer. Gastroenterology 2003;125:1645-1650.
7. Pignone M, Saha S, Hoerger T, Mandelblatt J. Cost-effectiveness analyses of colorectal cancer screening: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 2002;137:96-104.
8. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2009. CA Cancer J Clin 2009;59: 225-249.
9. Burt RW. Colon cancer screening. Gastroenterology 2000;119:837-853.
10. Winawer S, Fletcher R, Rex D, et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale-update based on new evidence. Gastroenterology 2003;124:544-560.
11. Esserman L, Shieh Y, Thompson I. Rethinking screening for breast cancer and prostate cancer. JAMA 2009;302:1685-1692.
12. Winawer SJ, Zauber AG, Fletcher RH, et al. Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the U.S. Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. Gastroenterology 2000;130:1872-1885.
13. Walsh JM, Terdiman HP. Colorectal cancer screening: clinical applications. JAMA 2003;289:1297-1302.
14. Bressler B, Lo C, Amar J, et al. Prospective evaluation of screening colonoscopy: who is being screened? Gastrointest Endosc 2004;60:921-926.
15. Gross CP, Andersen MS, Krumholz HM, et al. Relation between Medicare screening reimbursement and stage at diagnosis for older patients with colon cancer. JAMA 2006;296: 2815-2822.
16. Ransohoff DF, Sandler RS. Clinical practice: screening for colorectal cancer. N Engl J Med 2002;346:40-44.
17. Robertson DJ, Greenberg ER, Beach M, et al. Colorectal cancer in patients under close colonoscopic surveillance. Gastroenterology 2005;129:34-41.
18. Lakoff J, Paszat F, Saskin R, Rabeneck L. Risk of developing proximal versus distal colorectal cancer after a negative colonoscopy: a population-based study. Clin Gastroenterol Hepatol 2008;6:1117-1121.